Koyfin Home > Directory > Health Care > Arena Pharmaceuticals > Preferred Equity

Arena Pharmaceuticals Preferred Equity Chart (ARNA)

Arena Pharmaceuticals annual/quarterly Preferred Equity from 2000 to 2008.
  • Arena Pharmaceuticals Preferred Equity for the quarter ending September 09, 2008 was $56m a 2.96% increase of 2m year over year
  • Arena Pharmaceuticals Preferred Equity for the last 12 months ending September 09, 2008 was $56m a 2.96% increase of 2m year over year
  • Arena Pharmaceuticals Annual Preferred Equity for 2007 was $54m a 3.92% increase of 2m from 2006
  • Arena Pharmaceuticals Annual Preferred Equity for 2006 was $52m a 3.92% increase of 2m from 2005
  • Arena Pharmaceuticals Annual Preferred Equity for 2005 was $50m a 41.55% increase of 21m from 2004
Other Balance Sheet Metrics:
  • Arena Pharmaceuticals Total Assets for the quarter ending September 09, 2018 was $610m a 44.38% increase of 271m year over year
  • Arena Pharmaceuticals Other Liabilities for the quarter ending September 09, 2018 was $1m a -69.22% decrease of -1m year over year
  • Arena Pharmaceuticals Total Equity for the quarter ending September 09, 2018 was $531m a 61.01% increase of 324m year over year
View Chart On Koyfin

Quarterly ARNA Preferred Equity Data

09/2008$56m
06/2008$55m
03/2008$54m
12/2007$54m
09/2007$53m
06/2007$53m
03/2007$52m
12/2006$52m
09/2006$51m
06/2006$51m

Annual ARNA Preferred Equity Data

2007$54m
2006$52m
2005$50m
2004$29m
2003$26m
1999$18m